Aculys
is a Japan-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological and psychiatric diseases... Read moreAculys
is a Japan-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological and psychiatric diseases... Read more
News
Oct 18, 2023
OINDPnews
Aculys: Aculys says it will file NDA based on interim analysis of Japanese Phase 3 trial of NRL-1 (Valtoco) diazepam nasal spray
Oct 18, 2023
Medical Device News Magazine
Aculys: Aculys Pharma Delivers Positive Phase 3 Clinical Study Interim Analysis result of a Diazepam Nasal Spray | An Antiepileptic Drug for RX of Epileptic Seizures
Jan 25, 2023
Clinical Trials Arena
Aculys: Aculys Pharma starts Phase III EDS therapy trial
Jan 25, 2023
Biospectrum Asia
Aculys: Aculys Pharma and Four H initiate research collaboration using wearable devices to study sleep disorders in Japan
Jul 13, 2022
Biospectrum Asia
Aculys: Aculys Pharma, SUSMED to conduct world's first clinical trial using blockchain
Jan 25, 2022
BioSpace
Aculys: NEURELIS SIGNS EXCLUSIVE LICENSING AGREEMENT WITH ACULYS PHARMA FOR THE DEVELOPMENT AND COMMERCIALIZATION OF VALTOCO (DIAZEPAM NASAL SPRAY) IN JAPAN AND THE ASIA-PACIFIC REGION
Nov 24, 2021
Livemint
Aculys: SoftBank's Masayoshi Son next big bet: Sleep disorder cures
Aculys Competitors
1
2
3
4
5
6
7
8
9
10